| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/14/2004 | EP1436317A1 Molecules that block viral infectivity and methods of use thereof |
| 07/14/2004 | EP1436295A2 Crystalline forms of valacyclovir hydrochloride |
| 07/14/2004 | EP1436290A1 Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1436257A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 07/14/2004 | EP1436252A1 Hydroxyfattysulfonic acid analogs |
| 07/14/2004 | EP1436010A2 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions, and methods |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1436006A2 Viral inhibition by n-docosanol |
| 07/14/2004 | EP1436004A1 Crustaceans as production systems for therapeutic proteins |
| 07/14/2004 | EP1436002A1 Use of peptide vectors to improve the immune response to antigens |
| 07/14/2004 | EP1435998A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 07/14/2004 | EP1435997A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 07/14/2004 | EP1435996A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
| 07/14/2004 | EP1435993A2 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/14/2004 | EP1435992A2 Chemokines as adjuvants of immune response |
| 07/14/2004 | EP1435985A2 Medicament containing activated antithrombin iii |
| 07/14/2004 | EP1435974A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 07/14/2004 | EP1435973A1 Coadministration of transport protein with conjugated cobalamin to deliver agents |
| 07/14/2004 | EP1435958A1 Use of phosphorodiesterase iv inhibitors |
| 07/14/2004 | EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435948A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 07/14/2004 | EP1435946A2 Linked biaryl compounds |
| 07/14/2004 | EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435937A2 Composition comprising paracetamol and a bitterness masking component |
| 07/14/2004 | EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435928A1 Allicin |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435924A2 Therapeutic composition and use |
| 07/14/2004 | EP1435922A1 Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| 07/14/2004 | EP1435918A1 Highly compressible ethylcellulose for tableting |
| 07/14/2004 | EP1435907A2 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 07/14/2004 | EP1435788A2 Lysin-deficient bacteriophages having reduced immunogenicity |
| 07/14/2004 | EP1435786A1 Pesticidal formulations |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1263429B1 Antiviral therapy |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1210350B1 Water soluble sdz-rad esters |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1037887B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP0984774B1 Gastroretentive controlled release microspheres for improved drug delivery |
| 07/14/2004 | EP0961775B1 Purine l-nucleosides, analogs and uses thereof |
| 07/14/2004 | EP0730601B1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | CN1512994A Water soluble porphyri nderivatives for photodynamic therapy, their use and manufacture |
| 07/14/2004 | CN1512992A Novel adenine derivatives |
| 07/14/2004 | CN1512991A 吡咯烷双环化合物 Pyrrolidine bicyclic compound |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512895A Use of polyclonal immunoglobulins |
| 07/14/2004 | CN1512894A Monocyte specific particulate delivery vehicle |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512890A HCG formulation |
| 07/14/2004 | CN1511848A Branched chain polyethylene glycol-integrated int3erferon composition and preparation |
| 07/14/2004 | CN1511844A Pig pleuropneumonia actino bacillus gene engineering toxoid ApxI and dead bacterium mixed vaccine |
| 07/14/2004 | CN1511843A Novel cynthetic antibiotic peptide and its preparing method and use |
| 07/14/2004 | CN1511834A Immune regulation and biological therapeutic function of benzo-isoselenazole derivatives |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511820A Novel intemediate for preparing 4-hydroxy-2-oxygen-pyran derivatives as protease inhibitor |
| 07/14/2004 | CN1511587A Process for preparing Vero cell epidemic cold purified vaccine and its use |
| 07/14/2004 | CN1511585A Polyglycol-interferon water solution |
| 07/14/2004 | CN1511584A Insect-ant capsule |
| 07/14/2004 | CN1511578A Medicine for treating erysipelas |
| 07/14/2004 | CN1511546A Chinese medicine for treating tuberculosis |
| 07/14/2004 | CN1157482C Compond with anti fungus activity and its preparing method |
| 07/14/2004 | CN1157405C Preparation method of cholera toxin B sub unit |
| 07/14/2004 | CN1157404C Novel fusidic acid derivatives |
| 07/14/2004 | CN1157402C Organic compounds |
| 07/14/2004 | CN1157396C Process for production of levo-ofloxacin |
| 07/14/2004 | CN1157391C Method and intermediate for preparing is-a-oxazole formylamine and its analogue |
| 07/14/2004 | CN1157389C Quinolinecarboxylic acid derivative or salts thereof |
| 07/14/2004 | CN1157386C Trisubstituted 1,3,5-triazine derivatives for treatment by HIV infections |
| 07/14/2004 | CN1157226C Stable alpha-interferon preparation |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157217C Spraying medicine for treating tinea pedis and process for making same |
| 07/14/2004 | CN1157203C Chinese medicine external use lotion for treating skin diseases and its preparing method |
| 07/14/2004 | CN1157192C Pharmaceutical application of crust holoside and derivant thereof |
| 07/14/2004 | CN1157190C Application of sodium deoxy taurocholate as synergist for antituber culosis antibiotic |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762189 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives |
| 07/13/2004 | US6762187 Heterocyclic nitrogen compounds used as enzyme inhibitors for prophylaxis of human immunodeficiency virus(hiv) |
| 07/13/2004 | US6762181 Broad antibacterial activity including drug resistant staphylococcus aureus (mrsa), pneumococcus (prsp) and enterococcus (vre); safely used in conjuction with nonsteroidal antiinflammatory drugs |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6762164 Use of 3-position cyclosporin derivatives for hair growth |
| 07/13/2004 | US6762051 Methods of inhibiting helicobacter pylori |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
| 07/13/2004 | US6761900 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 07/13/2004 | US6761894 Immune response against intracellular pathogens and in particular mycobacterium tuberculosis. |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/13/2004 | CA2192255C Treatment of chlamydia infectious diseases by rifamycin derivative |
| 07/13/2004 | CA2163212C Therapeutic compounds |